These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 11247108

  • 1. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ, Basson BR, Gilmore JA, Tollefson GD.
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
    Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD.
    J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
    [Abstract] [Full Text] [Related]

  • 3. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD, Beasley CM, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C, Tollefson GD.
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [Abstract] [Full Text] [Related]

  • 6. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD, Beasley CM, Tamura RN, Tran PV, Potvin JH.
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
    Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM, HGDH Study Group.
    Am J Psychiatry; 2003 Aug; 160(8):1396-404. PubMed ID: 12900300
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.
    J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
    [Abstract] [Full Text] [Related]

  • 9. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
    Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, García-Portilla MP, Fernández I, Hernández G, EIRE Study Group.
    Schizophr Res; 2003 Jul 01; 62(1-2):77-88. PubMed ID: 12765747
    [Abstract] [Full Text] [Related]

  • 10. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR, Mahmoud R.
    Am J Psychiatry; 2001 May 01; 158(5):765-74. PubMed ID: 11329400
    [Abstract] [Full Text] [Related]

  • 11. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb 01; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 12. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ.
    BMC Psychiatry; 2005 Jan 13; 5():3. PubMed ID: 15649317
    [Abstract] [Full Text] [Related]

  • 13. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.
    J Clin Psychiatry; 2004 Jan 13; 65 Suppl 18():47-56. PubMed ID: 15600384
    [Abstract] [Full Text] [Related]

  • 14. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA.
    Neuropsychopharmacology; 2004 Jan 13; 29(1):133-45. PubMed ID: 14583740
    [Abstract] [Full Text] [Related]

  • 15. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb 13; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

  • 16. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ, Roychowdhury SM, Milton DR, Hill AL.
    J Clin Psychiatry; 2001 Feb 13; 62 Suppl 2():17-21. PubMed ID: 11232746
    [Abstract] [Full Text] [Related]

  • 17. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV, Dellva MA, Tollefson GD, Beasley CM, Potvin JH, Kiesler GM.
    J Clin Psychiatry; 1997 May 13; 58(5):205-11. PubMed ID: 9184614
    [Abstract] [Full Text] [Related]

  • 18. Weight change and atypical antipsychotic treatment in patients with schizophrenia.
    Jones B, Basson BR, Walker DJ, Crawford AM, Kinon BJ.
    J Clin Psychiatry; 2001 May 13; 62 Suppl 2():41-4. PubMed ID: 11232752
    [Abstract] [Full Text] [Related]

  • 19. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S, Ameen S, Akhtar S.
    J Clin Psychopharmacol; 2008 Feb 13; 28(1):27-31. PubMed ID: 18204337
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
    Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V, Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine.
    JAMA; 2003 Nov 26; 290(20):2693-702. PubMed ID: 14645311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.